UK study finds ctDNA blood test can predict treatment response in advanced breast cancer
Breast cancer is a growing concern in India, with early detection crucial for survival. New research from London offers hope: a blood test detecting circulating tumor DNA (ctDNA) can predict treatment response in advanced cases. While promising, ctDNA is a risk factor, not a definitive cure predictor, and doesn't replace traditional biopsies for initial diagnosis.
Breast cancer is a growing concern in India, with early detection crucial for survival. New research from London offers hope: a blood test detecting circulating tumor DNA (ctDNA) can predict treatment response in advanced cases. While promising, ctDNA is a risk factor, not a definitive cure predictor, and doesn't replace traditional biopsies for initial diagnosis.
